Evaluation of Copper, Zinc, Cu/Zn, and VEGF in Patients with AML in Iran

Iranian Journal of Cancer Prevention

Volumn 4, Issue 4, 2011, Pages 151-153

  Sanaat, Z ^a   Nouri, M ^a   Hajipour, B ^b   Dolatkhah, R ^a   Asvadi, I ^a   Vaez, J ^a   Eivazi, J ^a   Nikanfar, A ^a   Esfahani, A ^a   Chavoshi, Sh ^a   Biorani, H ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Copper; Vascular endothelial growth factor A; Zinc

Indexed keywords

COPPER; CYTARABINE; DAUNORUBICIN; IDARUBICIN; VASCULOTROPIN; ZINC;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER ZINC RATIO; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GENDER; HUMAN; IRAN; MALE; NUTRITIONAL PARAMETERS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ZINC BLOOD LEVEL;

EID: 80053947717     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nasulewicz A, Mazur A, Opolski A. Role of copper in tumor angiogenesis-clinical implication. JTrace Elem Med Biolo 2004; 18(1): 1-8.
2. Brewer G. Copper control as an antiangiogenic anticancer therapy. Exp Biol Med; 2001: 226(7): 665-73.
3. Harris E.A Requirement for copper in angiogenesis. Nutr Rev. 2004; 62(2): 60-4.
4. Dvorak HF. Angiogenesis. J of Thr and Haem. 2005; 3: 1835-42.
5. Camphausen K, Sproull M, Tantama S, Sankineni S. Evaluation of copper chelation Agents as Anti-Angiogenic Therapy. Bioor & Med chem. 2003; 11:4287-930.
6. Daniel KG, Harbach RH, Guida Wc, Dou QP. Copper storage diseases. Front Biosci. 2004; 1; 9:2652-62.
7. Vanchieri C. Cutting Copper Curbs angiogenesis Studies show. J of NCI. 2000; 92(15): 1202-3.
8. Russel RM. Vitamin and Trace Mineral Deficiency and Excess. Kasper D, Fuci A, Longo D.Harrisons Principal of Internal Medicine: 17th.new York; McGrow -Hill, 2005; 409-10.
9. Holcatova B. Environmental epidemiology of malignancies: The natural European perspective. Center Eur J Publ HLt. 1998; 6(1):13-7.
10. Benanti JA, Williams DK, Robinson KL, Ozer HL.Induction of extacellular matrix-remodeling genes by the senescence-associated protein APA-1. Mol Cell Biol. 2002; 22(21): 7365-97.
11. Qiang Liu. Zinc Finger proteins to study Breast cancer angiogenesis. Pro Natl Acad Sci USA. 1997; 94(11):5525-30.
12. Powell RS. The antioxidant properties of zinc. J Nutr. 2000; 130:1447-54.
13. Yoshida D, keda Y, Nakazowa S. Copper chelation Inhibits Tumor Angiogenesis in the Experimental 9LGliosarcoma Model. Neurosurg. 1995; 37(2):287-92.
14. Zarghami N, Asadi J, Mohammadzadeh G, Asadi Y. Levels of Copper, Zinc and Selenium in Serum and Tumor Cytosol Extracts in Breast Cancer Patient. Pharm Sci. 2008; 14(1):41-8.
15. Zarghami N, Mikaeili H, Ansarin KH, Mohajeri A, Hajhosseini R. Correlation between Serum Levels of Zinc and Copper and Telomerase Gene Expression in Lung Cancer Patients. Pharmaceutical Sciences. 2009; 14(4): 183-90.
16. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia.Blood.2000 1; 95(1):309-13.
17. Padro T, Ruiz S, Bieker R, Burger H. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood, 2000; 95(8):2637-44.